Treatment of scleroderma: an update (Q35073374)

6 August 2017

1 reference

title

Treatment of scleroderma: an update (English)

1 reference

6 August 2017

Sangeeta D Sule

1 reference

6 August 2017

Fredrick M Wigley

series ordinal

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

471-482

1 reference

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Improvement in skin thickening in systemic sclerosis associated with improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Novel therapy in the treatment of scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Development of agents for the treatment of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Cellular and molecular mechanisms of pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Selective Pulmonary Vasodilation Induced by Aerosolized Zaprinast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Preliminary thermographic evaluation of new nitroglycerine tape on the peripheral circulatory disturbance in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Acute vascular effects of estrogen in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Effects of nebivolol on human platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Clinical trials: types, design, and end-points

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Integrin signaling in fibrosis and scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

The role of vitronectin receptor (alphavbeta3) and tissue factor in the pathogenesis of transplant coronary vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

Effect of antibody against integrin alpha4 on bleomycin-induced pulmonary fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.3.471

10.1517/13543784.12.3.471

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference